✨
AI Summary
- Cindy Eckert, angel investor and serial entrepreneur, sold Sprout Pharmaceuticals to Valeant for $1 billion after securing FDA approval for Addyi, the first female libido enhancement drug
- Her entrepreneurial journey includes previous company sales and reacquisition of Sprout after a lawsuit settlement, demonstrating persistence and business acumen
- Eckert's path from obscurity to billion-dollar success offers inspiration for anyone considering starting their own company or entering health tech innovation
